Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial.

  • Integrated BioBank of Luxembourg
July 25, 2016 By:
  • Biemann R
  • Penner M
  • Borucki K
  • Westphal S
  • Luley C
  • Ronicke R
  • Biemann K
  • Weikert C
  • Lux A
  • Goncharenko N
  • Marschall HU
  • Schneider JG
  • Isermann B.

Bile acids (BAs) are increasingly recognised as metabolic regulators, potentially improving insulin sensitivity following bariatric surgery. However, physiological relevance of such observations remains unknown. Hence, we analysed serum BA composition and associated gut-derived hormone levels following lifestyle-induced weight loss in individuals with metabolic syndrome (MetS). 74 non-smoking men (45-55 yr) with MetS were randomised to a lifestyle-induced weight loss program (supervision via telemonitoring) or to a control arm. Before and after a 6 months intervention period clinical and laboratory parameters, body composition, serum BA profile, FGF-19, and GLP-1 concentrations were determined in fasting blood samples. 30 participants in the control and 33 participants in the treatment arm completed the study and were included in the data analysis. In participants of the treatment arm lifestyle-induced weight loss resulted in markedly improved insulin sensitivity. Serum levels of BA species and total GLP-1 decreased, while FGF-19 remained stable. Serum BA composition changed towards an increased 12alpha-hydroxylated/non-12alpha-hydroxylated ratio. None of these parameters changed in participants of the control arm. Our results demonstrate that improved metabolic control by lifestyle modifications lowers serum levels of BAs and GLP-1 and changes serum BA composition towards an increased 12alpha/non-12alpha ratio (ICTRP Trial Number: U1111-1158-3672).

2016 Jul. Sci Rep.6:30173.
Other information